I am a board-certified pathologist, physician scientist, and Director of the Biospecimen Repository and Histopathology Service at Rutgers Cancer Institute with special expertise in cancer biology and next-generation sequencing (NGS) for molecular oncology. I completed residency at the National Cancer Institute in Bethesda, followed by fellowships in pathology informatics from Harvard Medical School and molecular genetic pathology at the University of Pittsburgh Medical Center. My clinical responsibilites include sign-out of all molecular oncology cases generated at Rutgers Robert Wood Johnson University Hospital. I lead the Precision Medicine Initiative at Rutgers Cancer Institute where I present and make treatment recommendations based on genomic profiling of tumors at a weekly molecular tumor board. These treatment recommendations include clinical trials and off-label therapies, in addition to FDA approved agents, based on the tumor’s underlying molecular alterations and histologic subtype. I have extensive experience in clinical and research based genomic analysis of cancer specimens.